UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease ...

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease ...

The thought of having one or both lungs replaced may sound overwhelming, but it's improved the lives of thousands of people ...

The clearance makes Jascayd the first new drug for idiopathic pulmonary fibrosis in over a decade, but some analysts see it ...

A healthy diet is linked to improved lung function and reduced asthma risk, primarily via weight management, though it ...

Lung diseases like tuberculosis and cystic fibrosis can be difficult to treat. In part, that's because the two-dimensional models researchers use to study the diseases don't accurately reflect the ...

The University of Birmingham leads £1.55m research to assess the long-term effects of vaping on respiratory cells, immunity, ...

Nerandomilast, marketed as Jascayd by its manufacturer Boehringer Ingelheim, is the first therapy approved in more than 10 ...

Interstitial lung disease was a common adverse event with 10 of the 15 FDA-approved antibody-drug conjugates, according to data from FAERS.

If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...

Companies are advancing treatments to better control symptoms of chronic obstructive pulmonary disease ...

University of Queensland researcher Arutha Kulasinghe studied lung biopsies from the tumours of almost 250 patients with ...